These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6388070

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Function and surface phenotype of T lymphocytes infiltrating renal allografts in nonhuman primates treated with monoclonal antibodies.
    Nocera A, Cosimi AB, Colvin RB, Gesner ML, Fuller TC.
    Transplantation; 1989 Nov; 48(5):732-41. PubMed ID: 2573179
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T, Lehmann M, Flye MW.
    Transplantation; 1997 Jan 27; 63(2):284-92. PubMed ID: 9020332
    [Abstract] [Full Text] [Related]

  • 47. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
    Kirk AD, Tadaki DK, Celniker A, Batty DS, Berning JD, Colonna JO, Cruzata F, Elster EA, Gray GS, Kampen RL, Patterson NB, Szklut P, Swanson J, Xu H, Harlan DM.
    Transplantation; 2001 Aug 15; 72(3):377-84. PubMed ID: 11502964
    [Abstract] [Full Text] [Related]

  • 48. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A.
    Transplantation; 2002 Jun 15; 73(11):1736-42. PubMed ID: 12084995
    [Abstract] [Full Text] [Related]

  • 49. The mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes.
    Kanellopoulos JM, De Petris S, Leca G, Crumpton MJ.
    Eur J Immunol; 1985 May 15; 15(5):479-86. PubMed ID: 3873340
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Improved results using OKT3 as induction immunosuppression in renal allograft recipients with delayed graft function.
    Benvenisty AI, Cohen D, Stegall MD, Hardy MA.
    Transplantation; 1990 Feb 15; 49(2):321-7. PubMed ID: 2137654
    [Abstract] [Full Text] [Related]

  • 52. Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation.
    Carpenter CB, Kirkman RL, Shapiro ME, Milford EL, Tiney NL, Waldmann TA, Zimmerman CE, Ramos EL, Strom TB.
    Am J Kidney Dis; 1989 Nov 15; 14(5 Suppl 2):54-7. PubMed ID: 2683758
    [Abstract] [Full Text] [Related]

  • 53. Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.
    Fung JJ, Demetris AJ, Porter KA, Iwatsuki S, Gordon RD, Esquivel CO, Jaffe R, Tzakis A, Shaw BW, Starzl TE.
    Nephron; 1987 Nov 15; 46 Suppl 1(Suppl 1):19-33. PubMed ID: 3306422
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
    Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP.
    Lancet; 1997 Oct 25; 350(9086):1193-8. PubMed ID: 9652559
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.
    Cosimi AB, Cho SI, Delmonico FL, Kaplan MM, Rohrer RJ, Jenkins RL.
    Transplantation; 1987 Jan 25; 43(1):91-5. PubMed ID: 3099442
    [Abstract] [Full Text] [Related]

  • 60. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.
    Cosimi AB, Colvin RB, Burton RC, Rubin RH, Goldstein G, Kung PC, Hansen WP, Delmonico FL, Russell PS.
    N Engl J Med; 1981 Aug 06; 305(6):308-14. PubMed ID: 6454075
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.